NEOSTRATA Refine Oil Control Gel 8 PHA/AHA 30ml
NeoStrata
SkincareOil-control gel / mattifying treatment
Certifications
- Cosmetic product formulated and marketed in line with applicable cosmetic regulations in regions of sale (e.g., EU/UK cosmetic regulations via listed responsible persons).
- Non Comedogenic and non Acnegenic as stated in brand and distributor literature.
- Fragrance Free formula, suitable for those avoiding perfumed products.
- Cosmetic product formulated and marketed in line with applicable cosmetic regulations in regions of sale (e.g., EU/UK cosmetic regulations via listed responsible persons).
- Non Comedogenic and non Acnegenic as stated in brand and distributor literature.
- Fragrance Free formula, suitable for those avoiding perfumed products.
Oil-control gel / mattifying treatment
Description
Lightweight, oil-free mattifying gel with 4% Gluconolactone (PHA) and 4% Mandelic Acid (AHA) designed to absorb excess oil, minimise the appearance of pores and reduce shine while gently exfoliating and smoothing the skin. Suitable for oily and acne-prone skin; non-comedogenic and non-acnegenic.
Bnefits
- Helps control excess sebum and reduce shine for a long-lasting matte finish.
- Minimises the appearance of enlarged pores for a more refined skin texture.
- 4% Gluconolactone provides gentle exfoliation and antioxidant, barrier-supporting benefits.
- 4% Mandelic Acid helps control oil and targets acne-causing (P. acnes) bacteria.
- Leaves the skin with a velvety, silky feel without heavy residue.
- Non-comedogenic and non-acnegenic, suitable for acne-prone skin.
- Oil-free gel texture layers well under sunscreen and makeup; can be used as a mattifying base or primer.
- Fragrance-free formulation suitable for those who are fragrance sensitive.
- Clinically, 77% of users reported reduced oil, minimized shine and smaller pores after 4 weeks of twice-daily use (brand claims).
- Part of the NEOSTRATA Refine/Clarify range targeted at oily and blemish-prone skin.
Indications
- Oily and combination skin with excess shine.
- Enlarged or visible pores, particularly in the T-zone.
- Acne-prone skin requiring an adjunctive, non-comedogenic oil-control product.
- Patients looking for a mattifying gel that can be used under makeup or sunscreen.
- Individuals with early signs of ageing and oiliness who benefit from gentle daily exfoliation with PHA/AHA.
Composition
- Aqua (Water)
- Cyclopentasiloxane
- Dimethicone
- Gluconolactone
- Mandelic Acid
- Glycerin
- Dimethicone Crosspolymer
- PEG/PPG-18/18 Dimethicone
- Polysorbate 20
- Sodium Chloride
- Silica Silylate
- Phenoxyethanol
- Caprylyl Glycol
- Chlorphenesin
- Ammonium Hydroxide
Formulation
- Oil-free, silicone-based gel with 8% total PHA/AHA (4% Gluconolactone and 4% Mandelic Acid).
- Mattifying and pore-refining formula combining sebum-absorbing silica with humectant glycerin.
- Fragrance-free, non-comedogenic and non-acnegenic cosmetic formulation.
- Designed specifically for oily and acne-prone skin within the NEOSTRATA Refine/Clarify portfolio.
Packaging
- 30 ml (1 oz) plastic tube or small bottle (depending on region) intended for targeted facial application.
- Outer carton in many markets listing full INCI ingredients, usage directions and regulatory cosmetic information.
- Professional/aesthetic channels (e.g. Fillers Direct) reference pack size as 30 ml.
Usage
- Apply a small amount of gel to cleansed skin, focusing on oily areas such as the T-zone.
- Use twice daily, morning and evening, or as directed by a skincare professional.
- Can be used alone or under moisturiser, sunscreen and/or makeup as a mattifying base.
- Avoid contact with eyes; if contact occurs, rinse thoroughly with water.
- Introduce gradually in routines that already include other exfoliating or active products to minimise irritation.
- As with all exfoliating acid products, use a broad-spectrum sunscreen during the day.
Contraindications
- Known hypersensitivity or allergy to Gluconolactone, Mandelic Acid, silicones, preservatives (e.g. Phenoxyethanol, Chlorphenesin) or any listed ingredient.
- Avoid use on broken, inflamed or severely irritated skin unless directed by a healthcare professional.
- Use with caution in individuals using multiple exfoliating acids or topical retinoids, which may increase irritation potential.
- Not intended for use inside the eyes or on mucous membranes; for external use only.
Adverse Effects
- Generally well tolerated; however, mild and transient stinging, tingling, or redness may occur, especially on compromised or very sensitive skin.
- Overuse or combination with other exfoliating treatments may lead to dryness, flaking or irritation.
- Rarely, allergic contact dermatitis or intolerance may develop; discontinue use and seek medical advice if significant redness, swelling, itching or rash occurs.
- As with other acid-containing products, slight photosensitivity is possible; inadequate photoprotection may increase the risk of sunburn or post-inflammatory pigmentation in susceptible individuals.
Storage Conditions
- Store at room temperature, ideally between 15–25 °C, away from excessive heat and direct sunlight.
- Keep the container tightly closed when not in use to maintain product integrity.
- Do not freeze.
- Keep out of reach of children.
Duration
Intended for ongoing daily use as part of an oil-control and/or acne-prone skincare regimen; no fixed treatment course is specified and duration should be guided by skin response and professional advice.
Onset
Mattifying and pore-blurring effects are typically immediate after application; clinical/brand data report visible improvements in oiliness, shine and pore appearance within approximately 4 weeks of twice-daily use.
